Effects of Rice Bran Oil on the Blood Lipids Profiles and Insulin Resistance in Type 2 Diabetes Patients

Overview

Journal J Clin Biochem Nutr

Specialty Biochemistry

Date 2012 Jul 17

PMID 22798707

Citations 11

Authors

Ming-Hoang Lai

Yi-Ting Chen

Ya-Yen Chen

Jui-Hung Chang

Hsing-Hsien Cheng

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to investigate the influence of rice bran oil consumption on plasma lipids and insulin resistance in patients with type 2 diabetes. Thirty-five patients with type 2 diabetes were randomly assigned to a placebo group or a rice bran oil group. The placebo group consumed 250 mL soybean oil-modified milk (18 g soybean oil) daily for 5 weeks, and the rice bran oil group consumed 250 mL rice bran oil modified milk (18 g rice bran oil) daily for 5 weeks. At week 0 and week 5, anthropometric measurements, hematology tests, and an oral-glucose-tolerance test were conducted. The results showed that the homeostasis model assessment index of insulin resistance, the area under the curve for postprandial serum insulin, and serum low-density-lipoprotein cholesterol concentrations increased significantly in the placebo group. In the rice bran oil group, fasting and 2-h postprandial blood glucose concentrations and the area under the curve for postprandial plasma glucose increased significantly; however, total serum cholesterol and low-density-lipoprotein cholesterol concentrations decreased significantly. However, the homeostasis model assessment index of insulin resistance was not significantly different. Consumption of 18 g rice bran oil modified milk daily for 5 weeks significantly decreased total serum cholesterol concentrations and tended to decrease low-density-lipoprotein cholesterol concentrations in patients with type 2 diabetes. However, no significant influence on insulin resistance was observed.

Citing Articles

Rice Bran Consumption Improves Lipid Profiles: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Park S, Kim Y, Park M, Kim J Nutrients. 2025; 17(1.

PMID: 39796546 PMC: 11723186. DOI: 10.3390/nu17010114.

Effects of Defatted Rice Bran-Fortified Bread on the Gut Microbiota Composition of Healthy Adults With Low Dietary Fiber Intake: Protocol for a Crossover Randomized Controlled Trial.

Ng H, Maggo J, Wall C, Bayer S, McNabb W, Mullaney J JMIR Res Protoc. 2024; 13():e59227.

PMID: 39207833 PMC: 11393501. DOI: 10.2196/59227.

An open label randomized controlled trial of the effects of rice bran oil on cardiometabolic risk factors, lipid peroxidation and antioxidant status in overweight/obese adults with metabolic syndrome.

Mahdavi-Roshan M, Shoaibinobarian N, Evazalipour M, Salari A, Ghorbani Z, Savarrakhsh A Lipids Health Dis. 2024; 23(1):273.

PMID: 39198792 PMC: 11350959. DOI: 10.1186/s12944-024-02260-4.

Hypolipidemic effect and modulation of hepatic enzymes by different edible oils in obese Wistar rats.

Alim M, Mumu T, Tamanna U, Khan M, Miah M, Islam M Heliyon. 2024; 10(4):e25880.

PMID: 38384579 PMC: 10878912. DOI: 10.1016/j.heliyon.2024.e25880.

Effects of Riceberry Rice Bran Oil Supplementation on Oxidative Stress and Cardiovascular Risk Biomarkers in Older Adults with Prehypertension.

Prasertsri P, Boonla O, Vierra J, Yisarakun W, Koowattanatianchai S, Phoemsapthawee J Prev Nutr Food Sci. 2023; 27(4):365-375.

PMID: 36721743 PMC: 9843719. DOI: 10.3746/pnf.2022.27.4.365.

References

Rivellese A, Patti L, Kaufman D, Zhu J, Annuzzi G, Vaccaro O . Lipoprotein particle distribution and size, insulin resistance, and metabolic syndrome in Alaska Eskimos: the GOCADAN study. Atherosclerosis. 2008; 200(2):350-8. PMC: 2638502. DOI: 10.1016/j.atherosclerosis.2007.12.041. View

Kuriyan R, Gopinath N, Vaz M, Kurpad A . Use of rice bran oil in patients with hyperlipidaemia. Natl Med J India. 2006; 18(6):292-6. View

Goldberg R, Mellies M, Sacks F, Moye L, Howard B, HOWARD W . Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care.... Circulation. 1998; 98(23):2513-9. DOI: 10.1161/01.cir.98.23.2513. View

Lam Y, Hatzinikolas G, Weir J, Janovska A, McAinch A, Game P . Insulin-stimulated glucose uptake and pathways regulating energy metabolism in skeletal muscle cells: the effects of subcutaneous and visceral fat, and long-chain saturated, n-3 and n-6 polyunsaturated fatty acids. Biochim Biophys Acta. 2011; 1811(7-8):468-75. DOI: 10.1016/j.bbalip.2011.04.011. View

Turner R, Millns H, Neil H, Stratton I, Manley S, Matthews D . Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ. 1998; 316(7134):823-8. PMC: 28484. DOI: 10.1136/bmj.316.7134.823. View

Yang Z, Miyahara H, Hatanaka A . Chronic administration of palmitoleic acid reduces insulin resistance and hepatic lipid accumulation in KK-Ay Mice with genetic type 2 diabetes. Lipids Health Dis. 2011; 10:120. PMC: 3155149. DOI: 10.1186/1476-511X-10-120. View

Madigan C, Ryan M, Owens D, Collins P, Tomkin G . Dietary unsaturated fatty acids in type 2 diabetes: higher levels of postprandial lipoprotein on a linoleic acid-rich sunflower oil diet compared with an oleic acid-rich olive oil diet. Diabetes Care. 2000; 23(10):1472-7. DOI: 10.2337/diacare.23.10.1472. View

Streicher R, Kotzka J, Muller-Wieland D, Siemeister G, Munck M, Avci H . SREBP-1 mediates activation of the low density lipoprotein receptor promoter by insulin and insulin-like growth factor-I. J Biol Chem. 1996; 271(12):7128-33. DOI: 10.1074/jbc.271.12.7128. View

Keys A . Serum cholesterol response to dietary cholesterol. Am J Clin Nutr. 1986; 44(2):309. DOI: 10.1093/ajcn/44.2.309. View

10.

Hanley A, Williams K, Stern M, Haffner S . Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care. 2002; 25(7):1177-84. DOI: 10.2337/diacare.25.7.1177. View

11.

Garvey W, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A . Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes. 2003; 52(2):453-62. DOI: 10.2337/diabetes.52.2.453. View

12.

Chen C, Cheng H . A rice bran oil diet increases LDL-receptor and HMG-CoA reductase mRNA expressions and insulin sensitivity in rats with streptozotocin/nicotinamide-induced type 2 diabetes. J Nutr. 2006; 136(6):1472-6. DOI: 10.1093/jn/136.6.1472. View

13.

Berger A, Rein D, Schafer A, Monnard I, Gremaud G, Lambelet P . Similar cholesterol-lowering properties of rice bran oil, with varied gamma-oryzanol, in mildly hypercholesterolemic men. Eur J Nutr. 2004; 44(3):163-73. DOI: 10.1007/s00394-004-0508-9. View

14.

Sugano M, Tsuji E . Rice bran oil and cholesterol metabolism. J Nutr. 1997; 127(3):521S-524S. DOI: 10.1093/jn/127.3.521S. View

15.

Chou T, Ma C, Cheng H, Chen Y, Lai M . A rice bran oil diet improves lipid abnormalities and suppress hyperinsulinemic responses in rats with streptozotocin/nicotinamide-induced type 2 diabetes. J Clin Biochem Nutr. 2009; 45(1):29-36. PMC: 2704324. DOI: 10.3164/jcbn.08-257. View

16.

Rajnarayana K, Prabhakar M, Krishna D . Influence of rice bran oil on serum lipid peroxides and lipids in human subjects. Indian J Physiol Pharmacol. 2002; 45(4):442-4. View

17.

Hunnicutt J, Hardy R, Williford J, McDonald J . Saturated fatty acid-induced insulin resistance in rat adipocytes. Diabetes. 1994; 43(4):540-5. DOI: 10.2337/diab.43.4.540. View

18.

Han M, Lim Y, Quan W, Kim J, Chung K, Kang M . Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance. J Lipid Res. 2011; 52(6):1234-1246. PMC: 3090244. DOI: 10.1194/jlr.M014787. View

19.

Franz M, Bantle J, Beebe C, Brunzell J, Chiasson J, Garg A . Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care. 2002; 25(1):148-98. DOI: 10.2337/diacare.25.1.148. View

20.

Hobbs F . Reducing cardiovascular risk in diabetes: beyond glycemic and blood pressure control. Int J Cardiol. 2005; 110(2):137-45. DOI: 10.1016/j.ijcard.2005.09.011. View